Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024. Which stocks will surge next?Unlock AI-picked Stocks

Procter & Gamble (PG) Beats On Q2 Earnings, Down On Sales Miss

Published 01/22/2020, 11:10 PM
Updated 07/09/2023, 06:31 AM

The Procter & Gamble Company (NYSE:PG) , popularly known as P&G, reported second-quarter fiscal 2020 results, wherein earnings per share surpassed the Zacks Consensus Estimate. However, sales missed the consensus mark. Nonetheless, earnings and sales improved on a year-over-year basis. Moreover, the company raised its guidance for fiscal 2020.

Procter & Gamble’s core earnings of $1.42 per share improved 14% year over year and outpaced the Zacks Consensus Estimate of $1.37. Meanwhile, currency-neutral core earnings per share (EPS) grew 15%.

The company reported net sales of $18,240 million, improving 4.6% year over year. However, sales missed the Zacks Consensus Estimate of $18,339 million. Currency fluctuations hurt the top line by one percentage point.

Despite strong bottom-line results, investors were disappointed by lower-than-expected sales. Consequently, the stock dipped 2% during the pre-market trading session. We note that shares of the Zacks Rank #2 (Buy) company have grown 34% in the past year, outperforming the industry’s 21.8% rally.



Sales in Detail

On an organic basis (excluding the impact of acquisitions, divestitures and foreign exchange), revenues grew 5% based on 3% rise in organic shipment volume. Further, organic sales benefited 1% each from increased pricing and favorable mix. The company mix benefited from strong organic sales growth in the Health Care segment as well as Skin and Personal Care categories, which have higher than company average selling prices.

Moreover, all of the company’s business segments reported organic sales growth. Organic sales improved 8% for the Beauty segment, 4% for Grooming, 7% for Health Care, 5% for Fabric & Home Care, and 1% for the Baby, Feminine and Family Care segment.

Net sales at Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine and Family Care segments grew 7%, 2%, 14%, 4% and 1%, respectively.

Margins

In the reported quarter, core gross margin increased 200 basis points (bps) year over year to 51.6%, including nearly 10 bps of adverse impact of foreign currency. On a currency-neutral basis, core gross margin expanded 210 bps, backed by gains from productivity savings, higher pricing, commodity cost declines and other benefits. This uptick was partly offset by unfavorable product mix.

Core and currency-neutral selling, general and administrative expenses (SG&A), as a percentage of sales, increased 20 bps to 26.9%. The increase was driven by higher marketing investments, inflation, digital investments, incentive compensation costs and other impacts. However, these were partly negated by savings from overhead and marketing expenses, and sales leverage benefit.

Moreover, core and currency-neutral operating margin expanded 190 bps to 24.7%, driven by 220 bps of total productivity cost savings.

Financials

Procter & Gamble ended the reported quarter with cash and cash equivalents of $6,279 million, long-term debt of $18,985 million, and total shareholders’ equity of $45,908 million.

Cash flow from operating activities amounted to $8,533 million for the first half of fiscal 2020, with operating cash flow of $4.4 billion in the fiscal second quarter. Moreover, adjusted free cash flow productivity was 100%.

Furthermore, the company returned $5.4 billion of cash to its shareholders in the fiscal second quarter. This included dividend payments worth $1.9 billion and share buybacks of $3.5 billion.

For fiscal 2020, the company increased its view for adjusted free cash flow productivity to 100% from 95% stated earlier. It anticipates paying out more than $7.5 billion in dividends and repurchasing $7-$8 billion of common shares in fiscal 2020. Earlier, the company had anticipated repurchasing shares worth $6-$8 billion.

Fiscal 2020 Guidance

Backed by strong organic sales growth, core earnings and returns to shareholders in the fiscal second quarter, Procter & Gamble raised its view for fiscal 2020. The company now projects all-in and organic sales growth of 4-5% compared with 3-5% mentioned earlier. The guidance includes a modest impact of adverse foreign currency, which is likely to be mostly offset by slight gain from acquisitions and divestitures.

Moreover, the company now projects core EPS growth of 8-11% for fiscal 2020 compared with 5-10% mentioned earlier. In fiscal 2019, it reported core earnings of $4.52 per share.

3 Other Top-Ranked Stocks to Watch

Colgate-Palmolive Company (NYSE:CL) has an expected long-term earnings growth rate of 4.3%. It currently carries a Zacks Rank #2. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

The Coca-Cola Company (NYSE:KO) presently has an expected long-term earnings growth rate of 6.6% and a Zacks Rank #2.

Monster Beverage Corporation (NASDAQ:MNST) has an expected long-term earnings growth rate of 14.3%. Currently, it carries a Zacks Rank #2.

The Hottest Tech Mega-Trend of All

Last year, it generated $24 billion in global revenues. By 2020, it's predicted to blast through the roof to $77.6 billion. Famed investor Mark Cuban says it will produce "the world's first trillionaires," but that should still leave plenty of money for regular investors who make the right trades early.

See Zacks' 3 Best Stocks to Play This Trend >>

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .


Monster Beverage Corporation (MNST): Free Stock Analysis Report

Coca-Cola Company (The) (KO): Free Stock Analysis Report

Colgate-Palmolive Company (CL): Free Stock Analysis Report

Procter & Gamble Company (The) (PG): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.